At a board meeting held on 11 June 2007, the Supervisory Board of H. Lundbeck A/S resolved, pursuant to the authorisation in article 4.3 of the company's articles of association, to issue warrants for up to a nominal value of DKK 5,000,000, corresponding to 1,000,000 shares. Members of H. Lundbeck A/S' Executive Management and Danish and foreign executives appointed by H. Lundbeck A/S' Executive Management who are employed by H. Lundbeck A/S or H. Lundbeck A/S' subsidiaries are eligible to receive warrants. The above-mentioned subsidiaries comprise Danish and foreign enterprises in which H. Lundbeck A/S directly or indirectly holds at least 50% of the shares. The plan will comprise about 90 employees. The plan will not comprise the members of the company's Supervisory Board. The Supervisory Board has determined the number of warrants that each member of the Executive Management may subscribe: Claus Bræstrup 53,000 warrants Lars Bang 40,000 warrants Stig Løkke Pedersen 40,000 warrants Furthermore, the Supervisory Board has determined that the new member of the Executive Management, Mr. Anders Götzsche, CFO, may subscribe for 40,000 warrants, provided that the CFO will accede to his position no later than 3 September 2007. Other Danish and foreign executives (80-90 executives) will on average be granted approximately 9,000 warrants. The warrants will be granted on 13 August 2007, however as regards the CFO the day of grant will be the day of accession, if the CFO accedes during the period from 14 August to 3 September 2007, both days included. Each warrant under the plan entitles the holder to subscribe 1 (one) Lundbeck share of DKK 5 nominal value. The subscription of shares will take place at a price per share of DKK 5 nominal value, corresponding to the average closing price of the H. Lundbeck A/S share on the Copenhagen Stock Exchange (all trades) on the business days during the period from 23 July 2007 to 27 July 2007, both days included, plus interest corresponding to 10% p.a. from 28 July 2007 until 1 August 2008 rounded down to the nearest whole number of kroner. The warrants can be exercised during the period from 1 August 2008 to 31 March 2011. The market value of the warrants granted is calculated using the Black Scholes formula and is based on a volatility of the Lundbeck share of 29, a dividend payout ratio of 1.44 %, a risk-free interest rate of 4.25 % and an average holding period of approximately 30 months. Applying these assumptions, the market value has been calculated at approximately DKK 20.60 per warrant, based on a price of the H. Lundbeck A/S share of DKK 130. For accounting purposes, the warrants will be recognised over the income statement at fair value (Black-Scholes) in Q3 2007. The content of this release will have no influence on the Lundbeck Group's financial result for 2007. Lundbeck contacts Investors: Media: Jacob Tolstrup Caroline Broge Investor Relations Manager, Media Relations Manager North America +45 36 43 26 38 +1 201 350 0187 ________________________ Stock Exchange Release No 278 - 13 June 2007 About Lundbeck H. Lundbeck A/S is an international pharmaceutical company engaged in the research and development, production, marketing and sale of drugs for the treatment of psychiatric and neurological disorders. In 2006, the company's revenue was DKK 9.2 billion (approximately EUR 1.2 billion or USD 1.6 billion). The number of employees is approximately 5,300 globally. For further information, please visit www.lundbeck.com
Previously submitted 13 June 2007: New incentive plan in the Lundbeck Group
| Source: H. Lundbeck A/S